Business
Is now the time to invest into the CSL (ASX:CSL) share price?

The CSL Limited (ASX: CSL) share price has taken a hammering in recent weeks, falling as low as $242.00 at the start of this month. At the time of writing, CSL shares are trading for $260.57, up 0.15%. The global biotech has struggled to regain its limelight due to COVID-19 vaccine concerns as well as plasma collections.
However, with the vaccine’s latest developments, is now the time to invest into CSL shares?
Vaccine update
The CSL share price has barely lifted off despite the positive news released on over the weekend.
According to reports, the Australian Therapeutic Goods Administration (TGA) advised it had approved local production of…
-
General17 hours ago
Byford rail extension opening marks final stage of Perth Metronet
-
Noosa News23 hours ago
Fatal traffic crash, Baringa – Sunshine Coast
-
General19 hours ago
Mango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business21 hours ago
What $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years